Skip to main content
Yanjiu Conference logo

Call for Papers – ICIPSCDM 2027, Macau

International Conference on Induced Pluripotent Stem Cells and Disease Modeling — ICIPSCDM 2027

Dates

9–10 March 2027

Venue

Macau, Macau

Field

Induced Pluripotent Stem Cells and Disease Modeling

Topics of ICIPSCDM 2027

Original papers are invited in Induced Pluripotent Stem Cells and Disease Modeling. Submit by 5 February 2027.

Submit Your Paper

Topics include, but are not limited to:

Stem Cell Technology Advances

  • Recent innovations in iPSC reprogramming techniques
  • Development of novel culture systems for iPSCs
  • Assessment of genome editing in disease modeling

Disease-Specific iPSC Models

  • Modeling neurodegenerative diseases using iPSCs
  • Exploring cardiovascular disease through patient-derived iPSCs
  • Leveraging iPSC models for metabolic disorder research

Translational Applications

  • Utilization of iPSCs in drug discovery processes
  • iPSCs for personalized medicine approaches
  • Ethical considerations in translating research to clinic

Cellular Mechanisms in Disease

  • Investigating differentiation pathways in disease contexts
  • Understanding cellular stress responses in iPSCs
  • Role of epigenetics in disease modeling with iPSCs

Regenerative Medicine Perspectives

  • iPSCs in tissue engineering applications
  • Challenges in using iPSCs for organ transplantation
  • Potential for iPSCs in regenerative therapies for degenerative diseases

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICIPSCDM 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Macau This March

Present your research, meet peers from over 50 countries and help shape the future of Induced Pluripotent Stem Cells and Disease Modeling.